Which has preferable earnings and valuation, DOCS or WAY?

Doximity has higher earnings, but lower revenue than Waystar. Doximity is trading at a lower price-to-earnings ratio than Waystar, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Doximity $644.86M 7.09 $196.05M $0.85 30.19 Waystar $1.10B 4.09 $112.09M $0.70 33.53

Is DOCS or WAY more profitable?

Doximity has a net margin of 25.48% compared to Waystar's net margin of 11.18%. Doximity's return on equity of 18.06% beat Waystar's return on equity. Company Net Margins Return on Equity Return on Assets Doximity 25.48% 18.06% 15.40% Waystar 11.18% 7.03% 4.75%

Does the media prefer DOCS or WAY?

In the previous week, Doximity had 3 more articles in the media than Waystar. MarketBeat recorded 10 mentions for Doximity and 7 mentions for Waystar. Waystar's average media sentiment score of 1.45 beat Doximity's score of 0.93 indicating that Waystar is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Doximity 7 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Waystar 5 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has preferable valuation & earnings, WAY or HTFL?

Waystar has higher revenue and earnings than Heartflow. Heartflow is trading at a lower price-to-earnings ratio than Waystar, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Waystar $1.10B 4.09 $112.09M $0.70 33.53 Heartflow $176.03M 24.64 -$116.79M -$1.83 N/A

Is WAY or HTFL more profitable?

Waystar has a net margin of 11.18% compared to Heartflow's net margin of -55.82%. Waystar's return on equity of 7.03% beat Heartflow's return on equity. Company Net Margins Return on Equity Return on Assets Waystar 11.18% 7.03% 4.75% Heartflow -55.82% -23.52% -18.66%

Does the media favor WAY or HTFL?

In the previous week, Heartflow had 7 more articles in the media than Waystar. MarketBeat recorded 14 mentions for Heartflow and 7 mentions for Waystar. Waystar's average media sentiment score of 1.45 beat Heartflow's score of 0.69 indicating that Waystar is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Waystar 5 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Heartflow 6 Very Positive mention(s) 2 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has preferable valuation and earnings, SDGR or WAY?

Waystar has higher revenue and earnings than Schrodinger. Schrodinger is trading at a lower price-to-earnings ratio than Waystar, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Schrodinger $255.87M 5.49 -$103.26M -$0.74 N/A Waystar $1.10B 4.09 $112.09M $0.70 33.53

Is SDGR or WAY more profitable?

Waystar has a net margin of 11.18% compared to Schrodinger's net margin of -20.98%. Waystar's return on equity of 7.03% beat Schrodinger's return on equity. Company Net Margins Return on Equity Return on Assets Schrodinger -20.98% -16.37% -8.19% Waystar 11.18% 7.03% 4.75%

Does the media prefer SDGR or WAY?

In the previous week, Waystar had 2 more articles in the media than Schrodinger. MarketBeat recorded 7 mentions for Waystar and 5 mentions for Schrodinger. Waystar's average media sentiment score of 1.45 beat Schrodinger's score of 1.08 indicating that Waystar is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Schrodinger 1 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Waystar 5 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has stronger earnings and valuation, CERT or WAY?

Waystar has higher revenue and earnings than Certara. Certara is trading at a lower price-to-earnings ratio than Waystar, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Certara $418.84M 2.75 -$1.60M -$0.45 N/A Waystar $1.10B 4.09 $112.09M $0.70 33.53

Is CERT or WAY more profitable?

Waystar has a net margin of 11.18% compared to Certara's net margin of -16.75%. Waystar's return on equity of 7.03% beat Certara's return on equity. Company Net Margins Return on Equity Return on Assets Certara -16.75% 3.86% 2.65% Waystar 11.18% 7.03% 4.75%

Which has preferable valuation and earnings, WAY or GDRX?

Waystar has higher revenue and earnings than GoodRx. Waystar is trading at a lower price-to-earnings ratio than GoodRx, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Waystar $1.10B 4.09 $112.09M $0.70 33.53 GoodRx $796.85M 1.46 $30.44M $0.04 84.75

Is WAY or GDRX more profitable?

Waystar has a net margin of 11.18% compared to GoodRx's net margin of 2.07%. GoodRx's return on equity of 7.22% beat Waystar's return on equity. Company Net Margins Return on Equity Return on Assets Waystar 11.18% 7.03% 4.75% GoodRx 2.07% 7.22% 2.53%

Does the media favor WAY or GDRX?

In the previous week, Waystar had 4 more articles in the media than GoodRx. MarketBeat recorded 7 mentions for Waystar and 3 mentions for GoodRx. Waystar's average media sentiment score of 1.45 beat GoodRx's score of 1.08 indicating that Waystar is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Waystar 5 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive GoodRx 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Waystar (WAY) Competitors

$23.47 0.00 (0.00%)

Closing price 09/11/2026 04:00 PM Eastern

Extended Trading

$23.65 +0.18 (+0.77%)

As of 08:18 AM Eastern

Compare

WAY vs. DOCS, HTFL, SDGR, CERT, and GDRX

Should you buy Waystar stock or one of its competitors? Waystar's main competitors and comparable companies include Doximity (DOCS), Heartflow (HTFL), Schrodinger (SDGR), Certara (CERT), and GoodRx (GDRX). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare technology" industry.

How does Waystar compare to Doximity?

Doximity (NYSE:DOCS) and Waystar (NASDAQ:WAY) are both mid-cap healthcare companies, but which is the better business? We will compare the two businesses based on the strength of their risk, analyst recommendations, dividends, media sentiment, institutional ownership, profitability, valuation and earnings.

Doximity has a beta of 1.25, meaning that its stock price is 25% more volatile than the broader market. Comparatively, Waystar has a beta of 0.16, meaning that its stock price is 84% less volatile than the broader market.

In the previous week, Doximity had 3 more articles in the media than Waystar. MarketBeat recorded 10 mentions for Doximity and 7 mentions for Waystar. Waystar's average media sentiment score of 1.45 beat Doximity's score of 0.93 indicating that Waystar is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Doximity	7 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Waystar	5 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Doximity has a net margin of 25.48% compared to Waystar's net margin of 11.18%. Doximity's return on equity of 18.06% beat Waystar's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Doximity	25.48%	18.06%	15.40%
Waystar	11.18%	7.03%	4.75%

87.2% of Doximity shares are held by institutional investors. 31.8% of Doximity shares are held by company insiders. Comparatively, 3.5% of Waystar shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Doximity currently has a consensus target price of $32.18, suggesting a potential upside of 25.41%. Waystar has a consensus target price of $35.14, suggesting a potential upside of 49.71%. Given Waystar's stronger consensus rating and higher possible upside, analysts plainly believe Waystar is more favorable than Doximity.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Doximity	4 Sell rating(s)	13 Hold rating(s)	7 Buy rating(s)	2 Strong Buy rating(s)	2.27
Waystar	0 Sell rating(s)	3 Hold rating(s)	20 Buy rating(s)	2 Strong Buy rating(s)	2.96

Doximity has higher earnings, but lower revenue than Waystar. Doximity is trading at a lower price-to-earnings ratio than Waystar, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Doximity	$644.86M	7.09	$196.05M	$0.85	30.19
Waystar	$1.10B	4.09	$112.09M	$0.70	33.53

Summary

Doximity beats Waystar on 10 of the 16 factors compared between the two stocks.

How does Waystar compare to Heartflow?

Waystar (NASDAQ:WAY) and Heartflow (NASDAQ:HTFL) are both mid-cap healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their media sentiment, institutional ownership, risk, analyst recommendations, dividends, valuation, earnings and profitability.

Waystar has a net margin of 11.18% compared to Heartflow's net margin of -55.82%. Waystar's return on equity of 7.03% beat Heartflow's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Waystar	11.18%	7.03%	4.75%
Heartflow	-55.82%	-23.52%	-18.66%

Waystar presently has a consensus target price of $35.14, suggesting a potential upside of 49.71%. Heartflow has a consensus target price of $44.88, suggesting a potential downside of 10.03%. Given Waystar's stronger consensus rating and higher possible upside, analysts clearly believe Waystar is more favorable than Heartflow.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Waystar	0 Sell rating(s)	3 Hold rating(s)	20 Buy rating(s)	2 Strong Buy rating(s)	2.96
Heartflow	1 Sell rating(s)	2 Hold rating(s)	8 Buy rating(s)	1 Strong Buy rating(s)	2.75

Waystar has higher revenue and earnings than Heartflow. Heartflow is trading at a lower price-to-earnings ratio than Waystar, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Waystar	$1.10B	4.09	$112.09M	$0.70	33.53
Heartflow	$176.03M	24.64	-$116.79M	-$1.83	N/A

In the previous week, Heartflow had 7 more articles in the media than Waystar. MarketBeat recorded 14 mentions for Heartflow and 7 mentions for Waystar. Waystar's average media sentiment score of 1.45 beat Heartflow's score of 0.69 indicating that Waystar is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Waystar	5 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Heartflow	6 Very Positive mention(s)	2 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Waystar beats Heartflow on 12 of the 14 factors compared between the two stocks.

How does Waystar compare to Schrodinger?

Schrodinger (NASDAQ:SDGR) and Waystar (NASDAQ:WAY) are both healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their dividends, media sentiment, institutional ownership, risk, earnings, profitability, analyst recommendations and valuation.

Schrodinger presently has a consensus price target of $20.50, indicating a potential upside of 7.78%. Waystar has a consensus price target of $35.14, indicating a potential upside of 49.71%. Given Waystar's stronger consensus rating and higher possible upside, analysts plainly believe Waystar is more favorable than Schrodinger.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Schrodinger	1 Sell rating(s)	3 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.29
Waystar	0 Sell rating(s)	3 Hold rating(s)	20 Buy rating(s)	2 Strong Buy rating(s)	2.96

In the previous week, Waystar had 2 more articles in the media than Schrodinger. MarketBeat recorded 7 mentions for Waystar and 5 mentions for Schrodinger. Waystar's average media sentiment score of 1.45 beat Schrodinger's score of 1.08 indicating that Waystar is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Schrodinger	1 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Waystar	5 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Waystar has a net margin of 11.18% compared to Schrodinger's net margin of -20.98%. Waystar's return on equity of 7.03% beat Schrodinger's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Schrodinger	-20.98%	-16.37%	-8.19%
Waystar	11.18%	7.03%	4.75%

79.1% of Schrodinger shares are owned by institutional investors. 10.1% of Schrodinger shares are owned by insiders. Comparatively, 3.5% of Waystar shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Waystar has higher revenue and earnings than Schrodinger. Schrodinger is trading at a lower price-to-earnings ratio than Waystar, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Schrodinger	$255.87M	5.49	-$103.26M	-$0.74	N/A
Waystar	$1.10B	4.09	$112.09M	$0.70	33.53

Schrodinger has a beta of 1.69, suggesting that its share price is 69% more volatile than the broader market. Comparatively, Waystar has a beta of 0.16, suggesting that its share price is 84% less volatile than the broader market.

Summary

Waystar beats Schrodinger on 13 of the 17 factors compared between the two stocks.

How does Waystar compare to Certara?

Certara (NASDAQ:CERT) and Waystar (NASDAQ:WAY) are both healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their dividends, media sentiment, institutional ownership, analyst recommendations, profitability, valuation, earnings and risk.

Waystar has higher revenue and earnings than Certara. Certara is trading at a lower price-to-earnings ratio than Waystar, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Certara	$418.84M	2.75	-$1.60M	-$0.45	N/A
Waystar	$1.10B	4.09	$112.09M	$0.70	33.53

In the previous week, Waystar had 6 more articles in the media than Certara. MarketBeat recorded 7 mentions for Waystar and 1 mentions for Certara. Certara's average media sentiment score of 1.85 beat Waystar's score of 1.45 indicating that Certara is being referred to more favorably in the media.

Company	Overall Sentiment
Certara	Very Positive
Waystar	Positive

Waystar has a net margin of 11.18% compared to Certara's net margin of -16.75%. Waystar's return on equity of 7.03% beat Certara's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Certara	-16.75%	3.86%	2.65%
Waystar	11.18%	7.03%	4.75%

74.0% of Certara shares are held by institutional investors. 1.1% of Certara shares are held by company insiders. Comparatively, 3.5% of Waystar shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Certara currently has a consensus target price of $8.28, suggesting a potential upside of 9.64%. Waystar has a consensus target price of $35.14, suggesting a potential upside of 49.71%. Given Waystar's stronger consensus rating and higher possible upside, analysts plainly believe Waystar is more favorable than Certara.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Certara	1 Sell rating(s)	5 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.45
Waystar	0 Sell rating(s)	3 Hold rating(s)	20 Buy rating(s)	2 Strong Buy rating(s)	2.96

Certara has a beta of 1.4, meaning that its stock price is 40% more volatile than the broader market. Comparatively, Waystar has a beta of 0.16, meaning that its stock price is 84% less volatile than the broader market.

Summary

Waystar beats Certara on 14 of the 17 factors compared between the two stocks.

How does Waystar compare to GoodRx?

Waystar (NASDAQ:WAY) and GoodRx (NASDAQ:GDRX) are both healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their earnings, risk, valuation, dividends, institutional ownership, profitability, analyst recommendations and media sentiment.

Waystar currently has a consensus price target of $35.14, suggesting a potential upside of 49.71%. GoodRx has a consensus price target of $4.23, suggesting a potential upside of 24.70%. Given Waystar's stronger consensus rating and higher probable upside, analysts clearly believe Waystar is more favorable than GoodRx.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Waystar	0 Sell rating(s)	3 Hold rating(s)	20 Buy rating(s)	2 Strong Buy rating(s)	2.96
GoodRx	3 Sell rating(s)	6 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.08

Waystar has a net margin of 11.18% compared to GoodRx's net margin of 2.07%. GoodRx's return on equity of 7.22% beat Waystar's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Waystar	11.18%	7.03%	4.75%
GoodRx	2.07%	7.22%	2.53%

Waystar has higher revenue and earnings than GoodRx. Waystar is trading at a lower price-to-earnings ratio than GoodRx, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Waystar	$1.10B	4.09	$112.09M	$0.70	33.53
GoodRx	$796.85M	1.46	$30.44M	$0.04	84.75

In the previous week, Waystar had 4 more articles in the media than GoodRx. MarketBeat recorded 7 mentions for Waystar and 3 mentions for GoodRx. Waystar's average media sentiment score of 1.45 beat GoodRx's score of 1.08 indicating that Waystar is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Waystar	5 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
GoodRx	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Waystar has a beta of 0.16, meaning that its share price is 84% less volatile than the broader market. Comparatively, GoodRx has a beta of 1.59, meaning that its share price is 59% more volatile than the broader market.

63.8% of GoodRx shares are held by institutional investors. 3.5% of Waystar shares are held by company insiders. Comparatively, 5.9% of GoodRx shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Summary

Waystar beats GoodRx on 12 of the 17 factors compared between the two stocks.

Get Waystar News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding WAY and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

WAY vs. The Competition

Export

Metric	Waystar	Healthcare Technology Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$4.50B	$1.70B	$7.15B	$12.84B
Dividend Yield	N/A	4.70%	2.57%	11.71%
P/E Ratio	33.53	20.43	275.24	25.35
Price / Sales	4.09	88.98	647.32	90.72
Price / Cash	12.04	31.57	28.42	34.96
Price / Book	1.16	5.97	10.33	6.21
Net Income	$112.09M	-$18.66M	$3.50B	$358.54M
7 Day Performance	-6.38%	-1.28%	-3.32%	-2.39%
1 Month Performance	-5.29%	1.31%	-0.87%	-3.39%
1 Year Performance	-37.18%	-14.56%	23.52%	8.81%

Waystar Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
WAY Waystar	4.7042 of 5 stars	$23.47 flat	$35.14 +49.7%	-37.2%	$4.50B	$1.10B	33.53	1,700	Positive News
DOCS Doximity	4.6233 of 5 stars	$26.28 -1.6%	$32.43 +23.4%	N/A	$4.68B	$655.57M	30.92	890	Gap Down
HTFL Heartflow	2.046 of 5 stars	$50.43 +0.1%	$43.43 -13.9%	+49.4%	$4.38B	$176.03M	N/A	699	Gap Down
SDGR Schrodinger	1.4561 of 5 stars	$20.84 +6.9%	$20.50 -1.6%	+2.4%	$1.54B	$255.87M	N/A	790	Positive News Gap Down
CERT Certara	1.8019 of 5 stars	$8.10 -2.3%	$8.28 +2.2%	-33.1%	$1.24B	$418.84M	N/A	1,576	Positive News

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:WAY) was last updated on 9/14/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Waystar (WAY) Competitors